The doctrine of issue preclusion, or collateral estoppel, prevents a party who unsuccessfully litigated an issue to a final decision in one proceeding from relitigating the same issue in future ...
Inter partes review—or “IPR”—has become a popular avenue for accused patent infringers to challenge the validity of a patent’s claims outside of federal court. Any interested party may file for IPR, ...
The China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains The China Patent Office ...
“Although for now this decision has opened the doors of state courts to claims of industrial design (and patent) invalidity, there is a chance the court might restrict the scope of this interpretation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results